Axsome Therapeutics Inc (AXSM)
R&D to Revenue
21.17%
Quarterly · Period ending:
AXSM R&D to Revenue
Latest reported21.17%period ending
Latest reported21.17%period ending
AXSM Quarterly R&D/Revenue (0.00% → 21.17%)
Latest values, visible window
High-resolution chart · PNG
AXSM r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 21.1686% | |
| 27.5503% | |
| 24.8935% | |
| 23.4876% | |
| 33.0181% | |
| 36.8713% | |
| 46.3146% | |
| 43.3249% | |
| 57.1932% | |
| 49.1073% | |
| 43.0631% | |
| 49.7751% | |
| 44.0707% | |
| 18.8134% | |
| 60.2879% | |
| 88.3118% | |
| 179.0476% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |